Regulatory

Showing of Insights Posts
Archived info
Advocating for better climate disclosures to improve investment outcomes
Members of our Sustainable Investment Team share recent advocacy efforts with policymakers and standard setters around the world.
Continue reading
event
Quick Take
2023-10-31
Archived info
Archived info
The critical role of ESG in private equity
Explore our full ESG insights for private companies series with our latest research on governance, DEI, climate, and much more.
Continue reading
event
Article
2024-10-31
Archived info
Archived info
Crypto beyond the hype: Insights for institutional investors
We highlight a few practical insights on cryptocurrencies for institutional investors evaluating the asset class, including our views on custody, regulation, and more.
Continue reading
event
Quick Take
2022-12-31
Archived info
Archived info
Why I’m getting more bullish on biotech
The biotechnology sector, especially SMID-cap biotech equities, suffered a dramatic drawdown in 2021. Investor sentiment toward the sector remains poor, but my outlook has become increasingly bullish as multiple headwinds facing biotech over the past year or so begin to abate and turn into potential tailwinds for 2022 and beyond. Encouragingly, the level of innovation across the industry has never been higher, in my view. I believe many biotech stocks may be nearing a bottom, even though the exact timing of (and catalyst for) a rebound remains unclear as of this writing.
Continue reading
event
Quick Take
2022-06-30
Archived info